Detalhe da pesquisa
1.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet
; 403(10427): 632-644, 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246194
2.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347950
3.
Naphthalene-Embedded Multi-Resonance Emitters Enabling Efficient Narrow Emissive Blue OLEDs.
Chemistry
; 29(61): e202301931, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423895
4.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
5.
Array testing for multiplex assays.
Biostatistics
; 21(3): 417-431, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30371749
6.
Real-world treatment duration in ALK-positive non-small-cell lung cancer patients receiving brigatinib through the early access program.
Future Oncol
; 16(15): 1031-1041, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338548
7.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
N Engl J Med
; 385(20): e70, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614319
8.
Hierarchical group testing for multiple infections.
Biometrics
; 73(2): 656-665, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27657666
9.
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Open Forum Infect Dis
; 10(7): ofad271, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37416758
10.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Open Forum Infect Dis
; 10(12): ofad598, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111750
11.
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Nat Med
; 29(10): 2615-2624, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770652
12.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 22(10): 1444-1454, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803290
13.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv
; 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159343
14.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv
; 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159344
15.
Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors.
J Med Econ
; 23(8): 894-901, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347754
16.
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma.
Pharmacoecon Open
; 4(3): 473-483, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605300